Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Mycoses × posaconazole × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neutropenia 1 Neoplasm, Residual 1 Myelodysplastic-Myeloproliferative Diseases 1 Mycoses 1 Leukemia, Myeloid 1

Interventions

Standard of Care 2 posaconazole 1 Itraconazole 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Merck Sharp & Dohme LLC

Phase 4 Completed

75 enrolled 14 charts

Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡